The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritis
Open accessAbstract
Objective: The concept that intraarticular crystals of uric acid by themselves trigger episodes of painful gouty arthritis is inconsistent with the clinical reality. Patients with large deposits of monosodium urate monohydrate (MSU) crystals (tophi) do not necessarily experience gouty attacks. In fact, it is the excessive consumption of food or alcohol that elicits the inflammation of the acute gout attack. The aim of this study was to identify the precise mechanism that initiates flares of gouty arthritis. Methods: Human peripheral blood mononuclear cells (PBMCs) and murine macrophages were stimulated in vitro with MSU, free fatty acids (FFAs), or both in combination. Thereafter, production of interleukin‐1β (IL‐1β) and activation of caspase 1 were determined. Gouty arthritis was induced in mice with deficiencies in the genes for caspase 1, ASC, NALP3, or IL‐1β, and the lack of inflammasome activity during joint swelling or other joint pathologic features was investigated in these mice. Results: MSU crystals had no biologic effects on PBMCs from healthy subjects, whereas the FFA C18:0 in the presence of MSU crystals induced the release of large amounts of IL‐1β following engagement of Toll‐like receptor 2 (TLR‐2). Interaction of FFAs, but not alcohol, with TLR‐2 synergized with MSU crystals to induce an inflammatory reaction. An important event of MSU/FFA‐induced acute joint inflammation is the activation of the inflammasome. MSU/FFA‐induced release of IL‐1β was dependent on activation of caspase 1 and ASC, but surprisingly, not NALP3. Conclusion: The synergistic effect between FFAs and MSU crystals leads to ASC/caspase 1–driven IL‐1β release. This mechanism could explain how constitutionally derived metabolic events initiate attacks of gout via the induction of IL‐1β–mediated joint inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Lee, J. Y., Sohn, K. H., Rhee, S. H., & Hwang, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011695200 · Cited by 1,299
Nguyen, M. T. A., Favelyukis, S., Nguyen, A.-K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G., & Olefsky, J. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706762200 · Cited by 1,035
A pilot study of IL-1 inhibition by anakinra in acute gout
So, A., De Smedt, T., Revaz, S., & Tschopp, J. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2143 · Cited by 727
Abdollahi-Roodsaz, S., Joosten, L. A. B., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R. D. J., Heuvelmans-Jacobs, M., Akira, S., Nicklin, M. J. H., Ribeiro-Dias, F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32639 · Cited by 527
Self-citationBlocking IL-1 in systemic inflammation
Dinarello, C. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050640 · Cited by 494
Chen, C.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28075 · Cited by 476
Update on gout: new therapeutic strategies and options
Terkeltaub, R. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.236 · Cited by 387
Coeshott, C., Ohnemus, C., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., & Cheronis, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6261 · Cited by 365
Terkeltaub, R., Sundy, J. S., Schumacher, H. R., Murphy, F., Bookbinder, S., Biedermann, S., Wu, R., Mellis, S., & Radin, A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108936 · Cited by 300
Joosten, L. A. B., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M. A., Sparrer, H., Pham, C. T., van der Meer, J. W. M., Dinarello, C. A., & van den Berg, W. B. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25006 · Cited by 296
Self-citationDi Giovine, F. S., Malawista, S. E., Nuki, G., & Duff, G. W. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.10.3213 · Cited by 232
di Giovine, F. S., Malawista, S. E., Thornton, E., & Duff, G. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115142 · Cited by 223
(1962) · JAMA · doi:10.1001/jama.1962.03050190031006 · Cited by 222
The role of interleukin‐1 and the inflammasome in gout: Implications for therapy
Pope, R. M., & Tschopp, J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22938 · Cited by 207
Sozio, M., & Crabb, D. W. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00011.2008 · Cited by 206
Fungal Zymosan and Mannan Activate the Cryopyrin Inflammasome
Lamkanfi, M., Malireddi, R. K. S., & Kanneganti, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023689 · Cited by 160
Self-citationGiamarellos‐Bourboulis, E. J., Mouktaroudi, M., Bodar, E. J., van der Ven, J., Kullberg, B.-J., Netea, M. G., & van der Meer, J. W. M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.082222 · Cited by 139
Self-citationBouwens, M., Afman, L. A., & Müller, M. M. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1515 · Cited by 130
Acute Ethanol Treatment Modulates Toll‐like Receptor‐4 Association with Lipid Rafts
Dolganiuc, A., Bakis, G., Kodys, K., Mandrekar, P., & Szabó, G. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00003.x · Cited by 94
Tramontini, N. L., Huber, C. M., Liu‐Bryan, R., Terkeltaub, R. A., & Kilgore, K. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20386 · Cited by 89
Bartonella quintanaLipopolysaccharide Is a Natural Antagonist of Toll-Like Receptor 4
Popa, C. D., Abdollahi‐Roodsaz, S., Joosten, L. A. B., Takahashi, N., Sprong, T., Matera, G., Liberto, M. C., Focà, A., van Deuren, M., Kullberg, B. J., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00237-07 · Cited by 88
Self-citationOak, S. A., Mandrekar, P., Catalano, D., Kodys, K., & Szabó, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7628 · Cited by 88
Inflammatory Role of ASC in Antigen-Induced Arthritis Is Independent of Caspase-1, NALP-3, and IPAF
Kolly, L., Karababa, M., Joosten, L. A. B., Narayan, S., Salvi, R., Pétrilli, V., Tschopp, J., van den Berg, W. B., So, A. K.-L., & Busso, N. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802173 · Cited by 87
Self-citationvan de Veerdonk, F. L., Joosten, L. A. B., Devesa, I., Mora-Montes, H. M., Kanneganti, T., Dinarello, C. A., van der Meer, J. W. M., Gow, N. A. R., Kullberg, B. J., & Netea, M. G. (2009) · The Journal of Infectious Diseases · doi:10.1086/597274 · Cited by 84
Self-citationDifferential function of the NACHT-LRR (NLR) members Nod1 and Nod2 in arthritis
Joosten, L. A. B., Heinhuis, B., Abdollahi‐Roodsaz, S., Ferwerda, G., Bourhis, L. L., Philpott, D. J., Nahori, M., Popa, C., Morré, S. A., van der Meer, J. W. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710445105 · Cited by 67
Self-citationCoeshott, C. M., Pilyavskaya, A., Ross, S., Wieczorek, M., Kroona, H., Leimer, A. H., & Cheronis, J. C. (1999) · Cited by 57
Cited by
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Self-citationDalbeth, N., Gosling, A. L., Gaffo, A., & Abhishek, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00569-9 · Cited by 1,338
NLRP3 inflammasome in cancer and metabolic diseases
Sharma, B. R., & Kanneganti, T.-D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00886-5 · Cited by 1,097
Self-citationDalbeth, N., Merriman, T. R., & Stamp, L. K. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00346-9 · Cited by 1,087
Metadata
- Authors
- Joosten, L. A. B., Netea, M. G., Mylona, E., Koenders, M. I., Malireddi, R. K. S., Oosting, M., Stienstra, R., van de Veerdonk, F. L., Stalenhoef, A. F., Giamarellos‐Bourboulis, E. J., Kanneganti, T., & van der Meer, J. W. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2010-10-29
- Volume
- 62
- Issue
- 11
- Pages
- 3237-3248
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2167255704
- Cited by
- 328
- References
- 33
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.